Neuronetics, Inc. STIM
Neuronetics, Inc. financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $149.2M | $74.9M | $71.3M | $65.2M | $55.3M | $49.2M | $62.7M | $52.8M | $40.4M |
| Gross profit | $72.3M | $54.2M | $51.7M | $49.7M | $43.7M | $37.7M | $47.3M | $40.3M | $30.8M |
| R&D expense | $6.6M | $12.8M | $9.5M | $9.3M | $7.9M | $9.2M | $13.7M | $8.2M | $7.9M |
| Operating income | -$31.4M | -$34.6M | -$30.6M | -$35.1M | -$27.6M | -$22.3M | -$26.9M | -$19.8M | -$13.6M |
| Interest expense | — | $7.3M | $5.4M | $4.3M | $4.0M | $4.5M | $3.7M | $3.7M | $2.8M |
| Net income | -$39.0M | -$43.7M | -$30.2M | -$37.2M | -$31.2M | -$27.5M | -$29.0M | -$24.1M | -$16.1M |
| EPS (diluted) | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 | $-1.46 | $-1.58 | — | — |
| Operating cash flow | -$20.4M | -$31.0M | -$32.0M | -$30.7M | -$28.0M | -$28.4M | -$30.5M | -$20.6M | -$11.1M |
| Cash & equivalents | $28.1M | $18.5M | $59.7M | $70.3M | $94.1M | $49.0M | $75.7M | $104.6M | $29.1M |
| Inventory | $4.3M | $4.2M | $8.1M | $8.9M | $6.6M | $3.7M | $2.8M | $2.4M | $2.5M |
| Total assets | $141.6M | $140.9M | $115.8M | $116.9M | $141.2M | $78.7M | $100.2M | $117.0M | $38.9M |
| Total liabilities | $115.3M | $109.1M | $81.6M | $59.8M | $56.0M | $53.2M | $52.3M | $46.0M | $44.5M |
| Shareholders' equity | $26.2M | $31.8M | $34.2M | $57.1M | $85.2M | $25.5M | $47.9M | $71.0M | -$192.7M |
Growth · year-over-year · Revenue CAGR 17.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +99.2% | +5.0% | +9.4% | +17.9% | +12.3% | -21.4% | +18.7% | +30.5% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.